CN Patent

CN105101952B — 托法替布口服持续释放剂型

Assigned to Pfizer Inc · Expires 2022-06-28 · 4y expired

What this patent protects

本发明涉及托法替尼及其药学上可接受的盐的口服持续释放制剂。本文所述的制剂具有期望的药代动力学特征。

USPTO Abstract

本发明涉及托法替尼及其药学上可接受的盐的口服持续释放制剂。本文所述的制剂具有期望的药代动力学特征。

Drugs covered by this patent

Patent Metadata

Patent number
CN105101952B
Jurisdiction
CN
Classification
—
Expires
2022-06-28
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.